Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion.
Tuo QZ, Liu Y, Xiang Z, Yan HF, Zou T, Shu Y, Ding XL, Zou JJ, Xu S, Tang F, Gong YQ, Li XL, Guo YJ, Zheng ZY, Deng AP, Yang ZZ, Li WJ, Zhang ST, Ayton S, Bush AI, Xu H, Dai L, Dong B, Lei P. · 2022
Read Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion. by Tuo QZ, Liu Y, Xiang Z, Yan HF, Zou T, Shu Y, Ding XL, Zou JJ, Xu S, Tang F, Gong YQ, Li XL, Guo YJ, Zheng ZY, Deng AP, Yang ZZ, Li WJ, Zhang ST, Ayton S, Bush AI, Xu H, Dai L, Dong B, Lei P. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8866433.txt.
Introduction
Tuo and co-authors link a clotting enzyme to a distinct form of brain cell death after stroke. Ischemic stroke kills neurons as blood flow stops and returns. Which death program dominates is still debated. Ferroptosis, an iron-driven death, is a rising suspect. The team used multi-omics profiling in rodent stroke models. Thrombin and the gene ACSL4 stood out as sharply altered. Their lipid products rose together.
The authors show thrombin freeing arachidonic acid inside cells. ACSL4 then builds that fat into ferroptosis-driving lipids. Blocking the pathway at several points eased injury. The rescue held in cell models and in living animals. The authors name the thrombin-ACSL4 axis a drug target. It could limit ferroptotic damage when flow returns. New stroke treatments are scarce, so the lead matters.
Catalog record
| CREATOR | Tuo QZ, Liu Y, Xiang Z, Yan HF, Zou T, Shu Y, Ding XL, Zou JJ, Xu S, Tang F, Gong YQ, Li XL, Guo YJ, Zheng ZY, Deng AP, Yang ZZ, Li WJ, Zhang ST, Ayton S, Bush AI, Xu H, Dai L, Dong B, Lei P. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion By Qing-zhang Tuo, Yu Liu, Zheng Xiang, Hong-Fa Yan, Ting Zou, Yang Shu, Xu-long Ding, Jin-jun Zou, Shuo Xu, Fei Tang, Yan-qiu Gong, Xiao-lan Li Published in: Signal Transduction and Targeted Therapy DOI: 10.1038/s41392-022-00917-z ABSTRACT Ischemic stroke represents a significant danger to human beings, especially the elderly. Interventions are only available to remove the clot, and the mechanism of neuronal death during ischemic stroke is still in debate. Ferroptosis is increasingly appreciated as a mechanism of cell death after ischemia in various organs. Here we report that the serine protease, thrombin, instigates ferroptotic signaling by promoting arachidonic acid mobilization and subsequent esterification by the ferroptotic gene, acyl-CoA synthetase long-chain family member 4 (ACSL4). An unbiased multi-omics approach identified thrombin and ACSL4 genes/proteins, and their pro-ferroptotic phosphatidylethanolamine lipid products, as prominently altered upon the middle cerebral artery occlusion in rodents. Genetically or pharmacologically inhibiting multiple points in this pathway attenuated outcomes of models of ischemia in vitro and in vivo. Therefore, the thrombin-ACSL4 axis may be a key therapeutic target to ameliorate ferroptotic neuronal injury during ischemic stroke. INTRODUCTION Stroke remains one of humanity’s biggest killers, including in developing countries.1–3 Ischemic stroke, which is the most common form,4 occurs as a result of a blood clot occluding blood vessels that serve the brain, which causes the brain to lose energy and oxygen supply. The resulting brain damage develops from 20 min and can persist up to 10 days post stroke;5 however, the consequences of stroke can last for years, where one-third of stroke patients are left permanently disabled.6 Restoration of blood flow to the brain, either pharmacologically or by mechanical thrombolysis, is the main management strategy for stroke. Recombinant tissue plasminogen activator (r-tPA) is the only Food and Drug Administration-approved medication, which functions as a serine protease to dissolve clots,7,8 and has been shown to promote brain plasticity through epidermal growth factor receptor signaling that leads to longer-term functional improvement.9 However, in routine clinical practice, only 11% of patients are eligible to receive r-tPA due to the limited time window after stroke, a moderate recanalization rate, and other clinical contraindications. Moreover, of those who receive r-tPA, clinical improvement is only observed in one-half of patients.10 Therefore, other treatments, especially those that can protect against neuronal death, are still urgently needed. Unfortunately, over the past 10 years, only antioxidants, statins, and anticoagulants have met their primary endpoints in phase III/IV clinical trials despite numerous preclinical discoveries of neuroprotective agents.11 This translational “roadblock” highlights the need to further understand the mechanisms that lead to cell damage and death after cerebral infarction. The pathophysiology of ischemic stroke provides possibilities for several cell death mechanisms to occur, which may be promising targets for intervention.11 For example, the lack of oxygen and glucose supply during ischemia severely limits ATP production, which is especially necessary for neurons to power the sodium–potassium pump that maintains membrane polarization.11 Failure to regulate the membrane potential of the neuron causes manifold toxic cascades including excitotoxicity, mitochondrial dysfunction, local acidosis, protein misfolding, and inflammation. Regarding the excitotoxicity cascade, depolarization of the membrane as a consequence of glucose and oxygen deprivation causes glutamate release that signals for intracellular calcium elevation in postsynaptic neurons that result in cell death by apoptosis and necroptosis.12 The ischemic core is the area of the brain most affected by the lesion of the stroke, where there is substantial cell death, whereas the penumbra is the volume surrounding the core that is damaged but has greater potential to be rescued with therapeutics. If the neurons survive this period of oxygen and glucose starvation, they may be challenged with secondary oxygen stress upon reperfusion. This is why targeting oxidative stress is a rational therapeutic approach in a disease that is (initially) complicated by oxygen deprivation. In particular, iron-dependent ferroptosis causes cell death by excess lipid peroxidation that may contribute to the death of neurons in stroke. We previously found that soluble tau protein, previously reported to mediate iron transport,13–15 decreases after transient focal ischemia, which contributed to iron elevation and neuronal damage in a mouse model of ischemic stroke.16 Inhibition of ferroptosis by ferrostatin-1 and liproxstatin-1 protected the brains from cerebral ischemic injury in mice.16,17 In addition, transcriptional changes consistent with ferroptosis have also been identified in hemorrhagic stroke models,18 and selenium supplementation to enhance glutathione peroxidase 4 activity, the key checkpoint for ferroptosis, ameliorates ferroptotic damage in ischemic and hemorrhagic stroke models.18,19 To investigate the key proteins or pathways that are responsible for ferroptosis initiation during cerebral ischemia/reperfusion (I/R), we applied an integrative multi-omics approach, to survey the key metabolomics altered, and identify the essential primers of ferroptotic damage in ischemic stroke models. We used genetic or pharmacological modifications in rodents to verify the targets, and tested human samples to trace to the source of its alteration. These data may indicate a tractable target to prevent neuronal death after ischemic stroke. RESULTS Thrombin is upregulated after acute cerebral I/R While several studies11,16,18 have implicated ferroptosis in ischemic stroke, the mechanisms driving its activation remain unclear. Cell death caused by ferroptosis results from toxic lipid hydroperoxides that accumulate beyond the capacity of cells to detoxify.20–22 Arachidonic acid (AA) containing phosphatidylethanolamines (PEs) are particularly vulnerable to ferroptotic peroxidation.11,21 Using a high-quality untargeted metabolomic analysis of hippocampal tissue after ischemic stroke in mice (Fig. 1a), we identified four significantly reduced phospholipids, namely PC (36: 4), PE (42: 8), PE (38: 6p), and PE (40: 7) (Fig. 1b–h). Further analysis of their fatty acid side chains revealed that the fatty acid side chains of PC (36: 4, 16: 0/20: 4), PE (42: 8, 22: 4/20: 4), and PE (38: 6p, 18: 2p/20: 4) contain AA (Fig. 1i), and AA (20:4) was the dominant (Fig. 1j), which was consistent with that dramatically increased free AA in the hippocampal tissues after ischemic stroke in mice (stroke/control ratio = 1.49, p = 0.0007, Student’s t test, Fig. 1k).Fig. 1Arachidonic acid on the side chain of phospholipid is released after ischemia/reperfusion. a t-Distributed Stochastic Neighbor Embedding (tSNE) analysis shows remarkable stability of the instrument and good reproducibility of samples. b Heatmap analysis of the different expression (DE) lipids in contralateral (Contra) group and ipsilateral (Ipsi) group. The DE lipids were selected by VIP > 1, which was calculated by OPLS-DA analysis, and p value <0.05 (t test). c Different expression lipids in the Ipsi group. Values are shown as log2 fold change relative to the Contra group. Each dot denotes one lipid type, and the dot color represents lipid class, and the dot size shows significance (t test). d–g The abundance of PC (36:4, 16:0/20:4), PE (42:8, 22:4/20:4), PE (38:6, 18:2/20:4), and PE (40:7, 18:1/22:6) are significantly downregulated in Ipsi group. Data are mean ± SEM, n = 6. t test was performed. h The correlation among the 69 significantly changed lipids between Contra and Ipsi. The color of a node represents the ratio (Ipsi/Contra) of the lipids. The wathet edge shows a negative, and the orange edge indicates a positive correlation. i The ion characteristic fragments for the four reduced lipids. j The statistics of the fatty acid side chain of the four reduced lipids. k AA contents of